Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "diphtheria toxin-sensitive cell machinery" denotes the collective set of host components required for diphtheria toxin entry and cytotoxicity. The most critical component is the heparin-binding EGF-like growth factor receptor (HB-EGF receptor), which acts as the cell surface receptor mediating binding and internalization of diphtheria toxin[1][7]. Upon binding, the toxin-receptor complex is internalized via clathrin-mediated endocytosis, where acidification in endosomes facilitates membrane insertion and translocation of the catalytic A subunit into the cytosol. Intracellular chaperone systems including Hsp90 and co-chaperones assist with efficient cytosolic translocation of the enzymatic domain[3]. The diphtheria toxin A subunit ADP-ribosylates and inactivates elongation factor 2 (EF-2), causing cessation of protein synthesis and rapid cell death[6]. This machinery collectively determines cellular susceptibility to diphtheria toxin and can be experimentally targeted for cell ablation in research applications or forms the basis for understanding diphtheria pathology[1][3][6][7].
Toxin binds to HB-EGF receptor, triggers endocytosis, toxin enters cytosol via endosomal acidification, enzymatic inhibition of elongation factor 2 (EF-2) by ADP-ribosylation, leads to inhibition of protein synthesis and cell death[1][3][5][6][7].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparin-binding EGF-like growth factor receptor (HB-EGF receptor).